Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
We analyzed the effects of Bardoxolone-methyl (BAR), a small molecule activating agents of Nrf2 transcription factor, on cell migration and glucose metabolism in human breast cancer MCF-7 cells. BAR inhibited glycolysis, mitochondrial oxidative phosphorylation, and cell migration via increase in intracellular reactive oxygen species and decrease in glutathione level.
|